Why Are Lonmin Plc, Oxford BioMedica plc & Bango plc Among Today’s Biggest Gainers?

Should you buy or sell these 3 major gainers? Lonmin Plc (LON: LMI), Oxford BioMedica plc (LON: OXB) and Bango plc (LON: BGO)

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Shares in Lonmin (LSE: LMI) have soared by over 5% today after the mining company announced the appointment of a new CFO. Barrie van der Merwe will take over on 17 May and the market seems to have welcomed this prompt decision by the company following the resignation of Simon Scott.

Clearly, this is a time of major change for Lonmin as it seeks to implement an updated strategy in response to exceptionally difficult trading conditions. As part of this, it is restructuring its business and also seeking to cut costs; both of which are likely to have a positive impact on Lonmin’s bottom line over the medium to long term. And with Lonmin having the capital through which to effect its new plan following last year’s fundraising, its future seems to be brighter than it was just a handful of months ago.

This increased confidence plus a more stable commodity price environment has led to a rise in Lonmin’s share price of 99% since the turn of the year. This rapid increase could continue, although Lonmin remains a relatively high risk play and may only be of interest to less risk averse investors.

Also rising today are shares in Oxford BioMedica (LSE: OXB), with them being up over 11% despite no significant news flow having been released by the company today. In fact, the gene therapy specialist has not released an update since 7 March when it announced a new and expanded collaboration with Immune Design Corp. Since then its shares have fallen by around 6% but looking ahead, the company has clear potential to deliver profitability.

The challenge for investors, though, is that profitability may still be a long way off. And in the meantime Oxford BioMedica is in a cash burn phase which could require further fundraisings following its £8.1m placing in February. As such, and while Oxford BioMedica has a bright long term future in a very appealing space, it may only be worth a closer look for less risk averse investors.

Meanwhile, shares in mobile payments company Bango (LSE: BGO) have risen by 12% today despite a lack of news flow. Despite this, its shares have still fallen by 60% since the turn of the year even though Bango’s full-year results have showed that it is making progress. For example, it experienced significant growth in end user spend, with the company also doubling the rate of spending through the Bango payment platform. And with a stable cost base, it seems to be well-positioned to move towards profitability.

Of course, the market seems to be somewhat downbeat on Bango’s prospects judging by its recent share price fall. While today’s upward movement could indicate a change in sentiment, it may be prudent to await confirmation of this over the medium term before piling in.

Peter Stephens has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Hand of person putting wood cube block with word VALUE on wooden table
Investing Articles

A P/E ratio of less than 7. Is this a red-hot value share to consider now?

James Beard uses a popular tool to identify a UK share that’s potentially undervalued. But he reckons judgement is also…

Read more »

Businessman with tablet, waiting at the train station platform
Investing Articles

£5,000 invested in cheap BP shares a month ago is now worth…

BP shares have rocketed by double-digit percentages over the last month. Can the FTSE 100 oil giant keep rising? Royston…

Read more »

This way, That way, The other way - pointing in different directions
Investing For Beginners

Why the next 4 weeks are going to be big for Barclays shares

Jon Smith points out upcoming earnings and ongoing geopolitical turmoil and explains how Barclays shares could be impacted in the…

Read more »

British flag, Big Ben, Houses of Parliament and British flag composition
Investing Articles

Scottish Mortgage has made a fortune on SpaceX and Tesla! Here are 5 UK stocks it owns

This FTSE 100 investment trust holds 101 growth stocks from around the globe, but only five from the UK. Which…

Read more »

Businessman hand stacking up arrow on wooden block cubes
Investing Articles

I think UK investors are missing out on this overlooked Dow Jones stock

Jon Smith flags a US stock in the Dow Jones index that has a price-to-earnings ratio over half the average,…

Read more »

Shot of an young mixed-race woman using her cellphone while out cycling through the city
Investing For Beginners

2 FTSE 100 shares that could outperform this year regardless of geopolitics

Jon Smith notes the volatile market but explains how to pick FTSE 100 shares that can be fairly insulated to…

Read more »

Man writing 'now' having crossed out 'later', 'tomorrow' and 'next week'
Investing Articles

With share prices rising, is now the time to hold off buying stocks?

Despite share prices rising, Stephen Wright thinks there are still opportunities for investors looking for stocks to consider buying.

Read more »

Smartly dressed middle-aged black gentleman working at his desk
Investing Articles

6% dividend yields and a P/E below 6! Here’s a FTSE 250 bargain share to consider

I love UK shares with low earnings multiples and high dividend yields. So I'm considering buying this cheap-as-chips FTSE 250…

Read more »